Article 1 to 10 out of 10 for "Carboplatin"
Ordered by
relevance
alphabet
date
Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients
(04 Sep 2008)
carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS... intravenously with paclitaxel and carboplatin every 3 weeks. Patients will receive four to six cycles of paclitaxel and carboplatin in conjunction with REOLYSIN(R...
Oncolytics Biotech Announces U.K. Phase II Clinical Trial Investigating REOLYSIN in Combination with Paclitaxel and Carboplatin
(16 May 2008)
carboplatin in patients with advanced head and neck cancers. The principal... and carboplatin indicated strong and durable responses in patients with advanced head... and carboplatin . Patients with a variety of advanced cancers, including head and neck...
Antisoma announces start of phase III lung cancer trial of ASA404
(14 Apr 2008)
Initiation triggers USD 25 million milestone payment from Novartis
carboplatin /paclitaxel) or a placebo plus chemotherapy (carboplatin /paclitaxel) as a control. The primary endpoint...
Novelos Therapeutics announces continued encouraging results in ongoing phase 2 ovarian cancer trial
(04 Apr 2008)
carboplatin ...-resistant ovarian cancer, with NOV-002 (in combination with carboplatin ...
UCB: Phase II results for CDP791 in non-small cell lung cancer support further clinical development
(01 Apr 2008)
carboplatin and paclitaxel chemotherapy in first line non-small cell lung cancer (NSCLC). Positive improvements...
TopoTarget and CuraGen Initiate NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
(16 Nov 2006)
carboplatin , paclitaxel, cis-retinoic acid...
FDA Approves Avastin in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
(16 Oct 2006)
carboplatin ... that patients receiving Avastin plus paclitaxel and carboplatin chemotherapy had..., compared to patients who received paclitaxel and carboplatin alone (based...
CuraGen and TopoTarget Initiate Clinical Program Evaluating Oral Administration of PXD101
(14 Aug 2006)
Phase I trial to establish the dose and frequency for oral PXD101 in patients with advanced solid tumors
carboplatin and paclitaxel for ovarian cancer, with cis...
CuraGen and TopoTarget Initiate NCI-sponsored Phase I Clinical Trial of PXD101 and Azacitidine
(10 Aug 2006)
carboplatin ...
Antisoma's AS1404 enhances effectiveness of Avastin in colon and lung cancer models
(03 Apr 2006)
carboplatin and paclitaxel...
Additional information matching your search term
Additional information was found matching your search for "Carboplatin" .
Top
